PARAVAX INC has a total of 16 patent applications. Its first patent ever was published in 1989. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are CHANGCHUN SR BIOLOGICAL TECH CO LTD, GADETA B V and BEIJING ZHONGHAI BIOTECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 4 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Machines | |
#4 | Measurement | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Unspecified technologies | |
#6 | Analysing materials | |
#7 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Dale Beverly | 6 |
#2 | Grieve Robert B | 6 |
#3 | Heath Andrew W | 5 |
#4 | Yamanaka Miles | 4 |
#5 | Tripp Cynthia Ann | 4 |
#6 | Frank Glenn R | 3 |
#7 | Stevenson Lynnor B | 3 |
#8 | Arfsten Ann | 3 |
#9 | Mika-Grieve Marcia | 2 |
#10 | Yamanake Miles K | 2 |
Publication | Filing date | Title |
---|---|---|
AU5186396A | Hematophagous insect calreticulin nucleic acid molecules, proteins and uses thereof | |
IL115671D0 | Use of protease inhibitors and protease vaccines to protect animals from flea infestation and flea protease proteins nucleic acid molecules and uses thereof | |
CA2149197A1 | Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture | |
AU6172194A | Defective sindbis virus vectors that express (toxoplasma gondii) p30 antigens | |
US5418137A | Flea membrane binding site proteins as screening tools | |
US5356622A | Flea midgut-supernatant vaccines | |
AU8537091A | Membrane-derived antiflea vaccines | |
US5015476A | Immunization implant and method |